Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Arbutus Biopharma Corp
13G
ABUS · 03879J100
|
8.0% |
9/4/2026
Event 9/4/2026
|
|||
| Whitefort Capital Master Fund, LP | 8.0% | ||||
| Whitefort Capital GP, LLC | 8.0% | ||||
| Whitefort Capital Management, LP | 8.0% | ||||
| Whitefort Capital Management GP, LLC | 8.0% | ||||
| David Salanic | 8.0% | ||||
| Joseph Kaplan | 8.0% | ||||
|
OmniAb, Inc.
13G/A
OABI · 68218J103
|
7.1% |
8/14/2026
Event 6/30/2026
|
|||
| Whitefort Capital Management, LP | 7.1% | ||||
| David Salanic | 7.1% | ||||
| Joseph Kaplan | 7.1% | ||||
|
Bally's Corp
13G/A
BALY · 05875B304
|
4.9% |
3/12/2026
Event 3/12/2026
|
|||
| Whitefort Capital Management, LP | 4.9% | ||||
| David Salanic | 4.9% | ||||
| Joseph Kaplan | 4.9% | ||||
|
INNOVATE Corp.
13G/A
VATE · 45784J303
|
7.8% |
11/14/2025
Event 9/30/2025
|
|||
| Whitefort Capital Management, LP | 7.8% | ||||
| David Salanic | 7.8% | ||||
| Joseph Kaplan | 7.8% | ||||